Treatment ofStrongyloides stercoralishyperinfection-associated septic shock and acute respiratory distress syndrome with drotrecogin alfa (activated) in a renal transplant recipient

    loading  Checking for direct PDF access through Ovid

Abstract

J.M. Huston, S.R. Eachempati, J.R. Rodney, C. Cayci, D. Fusco, M. Mathew, J. Shou, M.J. Goldstein, S. Kapur, P.S. Barie. Treatment of Strongyloides stercoralis hyperinfection-associated septic shock and acute respiratory distress syndrome with drotrecogin alfa (activated) in a renal transplant recipient. Transpl Infect Dis 2009: 11: 277–280. All rights reserved

Abstract:

We report a case of Strongyloides stercoralis hyperinfection syndrome in a renal transplant recipient complicated by septic shock, acute respiratory distress syndrome, and Klebsiella pneumoniae superinfection. The patient was treated successfully with drotrecogin alfa (activated), parenteral ivermectin, albendazole, and piperacillin/tazobactam. This outcome suggests that drotrecogin alfa (activated) may be useful therapy for transplant recipients who develop severe sepsis or septic shock secondary to potentially lethal opportunistic infections.

Related Topics

    loading  Loading Related Articles